We are live on
!
Find out more
BM
Brandywine Managers Portfolio holdings
AUM
$202M
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter
Est. Return
-2.74%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$88.3M
AUM Growth
-$7.54M
(-7.9%)
Cap. Flow
-$2.06M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
72.69%
Holding
45
New
1
Increased
7
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$5.15M |
| 2 |
Samsara
IOT
|
+$251K |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$136K |
| 4 |
Relay Therapeutics
RLAY
|
+$117K |
| 5 |
AbCellera Biologics
ABCL
|
+$99.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$7.01M |
| 2 |
Salesforce
CRM
|
+$407K |
| 3 |
C3.ai
AI
|
+$233K |
| 4 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$205K |
| 5 |
Unity
U
|
+$168K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.31% |
| 2 | Consumer Staples | 33% |
| 3 | Healthcare | 19.08% |
| 4 | Communication Services | 0.52% |
| 5 | Industrials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$35.6B
| $781K | 0.89% |
4,608
| – | – |
|
|
27
Relay Therapeutics
RLAY
$4.17B
| $781K | 0.89% |
25,425
+3,702
| +17% | +$117K |
|
28
Teladoc Health
TDOC
$1.14B
| $700K | 0.79% |
7,627
| – | – |
|
29
Palo Alto Networks
PANW
$272B
| $688K | 0.78% |
7,410
| – | – |
|
|
30
Unity
U
$18.3B
| $627K | 0.71% |
4,386
-1,100
| -20% | -$168K |
|
31
ServiceNow
NOW
$146B
| $580K | 0.66% |
4,465
| – | – |
|
32
Schrodinger
SDGR
$1.5B
| $565K | 0.64% |
16,217
| – | – |
|
|
PLAN
33
DELISTED
Anaplan, Inc.
PLAN
| $545K | 0.62% |
11,888
+1,188
| +11% | +$65.5K |
|
|
34
AbCellera Biologics
ABCL
$3.7B
| $533K | 0.6% |
37,264
+6,545
| +21% | +$99.3K |
|
35
Roblox
RBLX
$30.9B
| $463K | 0.52% |
4,491
| – | – |
|
36
Fulcrum Therapeutics
FULC
$294M
| $447K | 0.51% |
25,280
+4,892
| +24% | +$96.9K |
|
37
Denali Therapeutics
DNLI
$3.56B
| $428K | 0.49% |
9,601
+1,050
| +12% | +$49.7K |
|
|
CELL
38
DELISTED
PhenomeX Inc. Common Stock
CELL
| $420K | 0.48% |
23,092
| – | – |
|
39
Seer Inc
SEER
$108M
| $351K | 0.4% |
15,366
| – | – |
|
40
SentinelOne
S
$6.92B
| $282K | 0.32% |
5,585
| – | – |
|
|
41
Samsara
IOT
$23.4B
| $270K | 0.31% |
+9,621
| New | +$251K |
|
42
Ionis Pharmaceuticals
IONS
$9.65B
| $257K | 0.29% |
8,460
| – | – |
|
|
SREV
43
DELISTED
ServiceSource International, Inc.
SREV
| $75K | 0.09% |
75,879
| – | – |
|
|
44
C3.ai
AI
$1.67B
| – | – |
-5,028
| Closed | -$233K |
|
|
TRHC
45
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| – | – |
-7,832
| Closed | -$205K |
|
Similar funds
OPL
WPW
HWA
DFG
LAMC
FC
ER
MRCM
Brandywine Managers's Q4 2021 Portfolio in Review
As of Q4 2021, Brandywine Managers held 45 positions worth $88.3M, down 7.9% from $95.8M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Brandywine Managers's Q4 2021 filing shows 1 new, 7 increased, 3 reduced and 2 closed positions. Its largest new stake was Samsara: 9,621 shares worth $270K. The largest sale was Keurig Dr Pepper, an estimated $7.01M.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 44% a quarter earlier, followed by Consumer Staples and Healthcare.
- Brandywine Managers's largest Q4 2021 buy was Samsara: 9,621 shares worth $270K.
- Brandywine Managers added most to UiPath in Q4 2021, an estimated $5.15M increase.
- Brandywine Managers's biggest Q4 2021 reduction was Keurig Dr Pepper, cutting an estimated $7.01M.
- Brandywine Managers fully exited C3.ai in Q4 2021, selling an estimated $233K.
- Brandywine Managers's ten largest holdings make up 73% of its $88.3M portfolio in Q4 2021.
- Brandywine Managers opened 1 new position and closed 2 in Q4 2021.
- Brandywine Managers's portfolio value fell 7.9% quarter-over-quarter to $88.3M.
Based on Brandywine Managers's 13F filing for Q4 2021, filed 10 Feb 2022.